← FDA Drug Approvals (Drugs@FDA)

JALYN

NDA · New Drug Application · Sponsor: WAYLIS THERAP · Approved 2010-06-14

Drug application

FDA Application #

NDA022460

Application type

New Drug Application

Brand name

JALYN

Generic name

DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE

Active ingredients

DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

WAYLIS THERAP

Manufacturer

Waylis Therapeutics

First approval

2010-06-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown